Cite
HARVARD Citation
Chiao, C. et al. (2022). Regional citrate and systemic heparin are adequate to maintain filter half‐life for COVID‐19 patients on continuous renal replacement therapy. Seminars in dialysis. 35 (4), pp. 325-329. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chiao, C. et al. (2022). Regional citrate and systemic heparin are adequate to maintain filter half‐life for COVID‐19 patients on continuous renal replacement therapy. Seminars in dialysis. 35 (4), pp. 325-329. [Online].